Latest Financial Results Show all Q3 2022 Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update Clearside Biomedical Q3 2022 Financial Results and OASIS Clinical Trial Data Call OASIS Phase 1/2a Clinical Trial Results Presentation 3.7 MB Form 10-Q Latest 10-K Group 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements Filing year - Any -20222021202020192018201720162015201420132012 View View HTML 0000950170-22-003468.pdf EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
